Abstract The Worldwide Network of Blood and Marrow Transplantation (WBMT) pursues the
mission of promoting hematopoietic cell transplantation (HCT) for instance by evaluating …

Cycle 2 ZR2 4.23 2.67 362 N/A 14.26% N/A Cycle 3 ZR2 3.52 1.0 255 N/A NEG N/A Cycle 4
ZR2 3.06 1.0 192 CR NEG N/A Cycle 5 ZR2 3.69 1.27 184 N/A NEG N/A Cycle 6 ZR2 3.04 …

Abstract Purpose of Review This review summarises the recent advances in knowledge
regarding the biology and treatment of prolymphocytic leukaemias. Recent Findings Both B …

Background B-cell prolymphocytic leukemia (B-PLL) is a rare mature B-cell tumor with an
aggressive clinical course and poor prognosis. It is characterized by prominent …

B‐cell prolymphocytic leukaemia (B‐PLL) is an aggressive B‐cell lymphoproliferative
disease with few clinically proven targeted treatments. Due to the rarity of the condition …

B-cell prolymphocytic leukemia (B-PLL) is a very rare lymphoid neoplasm accounting for
less than 0.5% of lowgrade mature B-cell lymphomas. 1-3 B-PLL is a poor-prognosis …

Objective: To discuss and analyze the clinical and prognostic characteristics of rare
prolymphocytic leukemia (PLL), in order to provide new references for the clinical diagnosis …

Interventions: The use of Ibrutinib as an effective treatment. Outcomes: The patient was in
complete remission after 5 months of Ibrutinib and then died of sudden aortic dissection …

B-cell prolymphocytic leukemia (B-PLL) is a rare lymphoid neoplasm accounting for
approximately 1% of all cases of lymphocytic leukemia. In this disease, TP53 abnormalities …

Background The B-cell prolymphocytic leukemia (B-PLL) diagnosis is challenging due to the
superposition with mature B-cell leukemia and/or lymphoma. Objective An insight case study …